Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156


Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisation.

Howell-Jones R, de Silva N, Akpan M, Oakeshott P, Carder C, Coupland L, Sillis M, Mallinson H, Ellis V, Frodsham D, Robinson TI, Gill ON, Beddows S, Soldan K.

Vaccine. 2012 Jun 6;30(26):3867-75. doi: 10.1016/j.vaccine.2012.04.006. Epub 2012 Apr 16.


Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England.

Mesher D, Soldan K, Howell-Jones R, Panwar K, Manyenga P, Jit M, Beddows S, Gill ON.

Vaccine. 2013 Dec 17;32(1):26-32. doi: 10.1016/j.vaccine.2013.10.085. Epub 2013 Nov 6.


Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study.

Oakeshott P, Aghaizu A, Reid F, Howell-Jones R, Hay PE, Sadiq ST, Lacey CJ, Beddows S, Soldan K.

BMJ. 2012 Jun 22;344:e4168. doi: 10.1136/bmj.e4168.


Investigating a cluster of vulvar cancer in young women: a cross-sectional study of genital human papillomavirus prevalence.

Rumbold AR, Tan SE, Condon JR, Taylor-Thomson D, Nickels M, Tabrizi SN, Davy ML, O'Brien MM, Connors CM, Zardawi I, Stankovich J, Garland SM.

BMC Infect Dis. 2012 Oct 5;12:243. doi: 10.1186/1471-2334-12-243.


The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.

C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.

Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.


Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.

Osborne SL, Tabrizi SN, Brotherton JM, Cornall AM, Wark JD, Wrede CD, Jayasinghe Y, Gertig DM, Pitts MK, Garland SM; VACCINE Study group.

Vaccine. 2015 Jan 1;33(1):201-8. doi: 10.1016/j.vaccine.2014.10.045. Epub 2014 Nov 1.


Risk of cervical HPV infection and prevalence of vaccine-type and other high-risk HPV types among sexually active teens and young women (13-26 years) enrolled in the VALHIDATE study.

Orlando G, Fasolo M, Mazza F, Ricci E, Esposito S, Frati E, Zuccotti GV, Cetin I, Gramegna M, Rizzardini G, Tanzi E; Valhidate Study Group.

Hum Vaccin Immunother. 2014;10(4):986-94. Epub 2014 Jan 15.


Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection.

Belinson JL, Hu S, Niyazi M, Pretorius RG, Wang H, Wen C, Smith JS, Li J, Taddeo FJ, Burchette RJ, Qiao YL.

Int J Cancer. 2010 Sep 1;127(5):1151-7. doi: 10.1002/ijc.25144.


Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.

Figueroa JP, Ward E, Luthi TE, Vermund SH, Brathwaite AR, Burk RD.

Sex Transm Dis. 1995 Mar-Apr;22(2):114-8.


Type-specific human papillomavirus infections among young heterosexual male and female STI clinic attendees.

Vriend HJ, Boot HJ, van der Sande MA; Medical Microbiological Laboratories; Municipal Health Services.

Sex Transm Dis. 2012 Jan;39(1):72-8. doi: 10.1097/OLQ.0b013e318235b3b0.


Spectrum of genital human papillomavirus infection in a female adolescent population.

Jamison JH, Kaplan DW, Hamman R, Eagar R, Beach R, Douglas JM Jr.

Sex Transm Dis. 1995 Jul-Aug;22(4):236-43.


Molecular epidemiology of the human papillomavirus infection in self-collected samples from young women.

de Almeida FG, Machado AP, Fernandes CE, Ferreira AT, Padovani CT, Tozetti IA.

J Med Virol. 2014 Feb;86(2):266-71. doi: 10.1002/jmv.23725. Epub 2013 Sep 5.


Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection.

Couture MC, Page K, Stein ES, Sansothy N, Sichan K, Kaldor J, Evans JL, Maher L, Palefsky J.

BMC Infect Dis. 2012 Jul 28;12:166. doi: 10.1186/1471-2334-12-166.


Prevalence of genital human papillomavirus DNA in a sample of senior school-aged women in the Australian Capital Territory.

O'Keefe EJ, Gardner A, Currie MJ, Garland S, Tabrizi S, Bowden FJ.

Sex Health. 2006 May;3(2):91-4.


Continuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study.

Mesher D, Panwar K, Thomas SL, Beddows S, Soldan K.

BMJ Open. 2016 Feb 11;6(2):e009915. doi: 10.1136/bmjopen-2015-009915.


Prevalence, concordance and determinants of human papillomavirus infection among heterosexual partners in a rural region in central Mexico.

Parada R, Morales R, Giuliano AR, Cruz A, Castellsagué X, Lazcano-Ponce E.

BMC Infect Dis. 2010 Jul 28;10:223. doi: 10.1186/1471-2334-10-223. Erratum in: BMC Infect Dis. 2011;11:25.


Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study.

Tay SK, Oon LL.

Int J STD AIDS. 2014 Dec;25(14):1013-21. doi: 10.1177/0956462414528315. Epub 2014 Mar 19.


The importance of low-risk HPV infection for the risk of abnormal cervical cytology/histology in more than 40 000 Danish women.

Nielsen A, Iftner T, Nørgaard M, Munk C, Junge J, Kjaer SK.

Sex Transm Infect. 2012 Dec;88(8):627-32. doi: 10.1136/sextrans-2011-050307. Epub 2012 Jul 6.


Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in Britain.

Johnson AM, Mercer CH, Beddows S, de Silva N, Desai S, Howell-Jones R, Carder C, Sonnenberg P, Fenton KA, Lowndes C, Soldan K.

Sex Transm Infect. 2012 Apr;88(3):212-7. doi: 10.1136/sextrans-2011-050306. Epub 2012 Jan 17.

Supplemental Content

Support Center